Skip to main content

Advertisement

Log in

Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Very few cases of patients with myasthenia gravis (MG) who later developed amyotrophic lateral sclerosis (ALS) have been described, although some studies showed that significantly more cases than expected have ALS associated with a prior diagnosis of autoimmune diseases. Our aim was to investigate whether the association of ALS and MG was higher than expected in a population-based study and to describe the clinical features characterizing these patients. In Emilia Romagna Region of Italy, a prospective registry has been collecting all incident ALS cases since 1.1.2009. For each patient, detailed clinical information is collected by caring physicians, including comorbidities. From 1.1.2009 to 31.12.2014, 671 patients were diagnosed with ALS; five patients (0.75%) were also affected by MG. Considering Western Countries incidence rates the occurrence of both the diseases should be a really exceptional event (7.5/109), compared to our findings (1.87/107) (p < 0.01). Patients with ALS and MG had more frequently a bulbar onset and a fast progressive course. These cases of ALS after MG raise the possibility of potential shared immunological dysfunctions, which may be expression of common pathogenic mechanisms, as well as of shared disease-course modulating events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Del Mar Amador M, Vandenberghe N, Berhoune N et al (2016) Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system? Neuromuscul Disord 26:342–346. doi:10.1016/j.nmd.2016.03.004

    Article  Google Scholar 

  2. Turner MR, Goldacre R, Ramagopalan S, Talbot K, Goldacre MJ (2013) Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study. Neurology 81:1222–1225. doi:10.1212/WNL.0b013e3182a6cc13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mandrioli J, Biguzzi S, Guidi C et al (2014) Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): a population based study. Amyotroph Lateral Scler Frontotempor Degener 15:262–268. doi:10.3109/21678421.2013.865752

    Article  Google Scholar 

  4. McGrogan A, Sneddon S, de Vries CS (2010) The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 43:171–183. doi:10.1159/000279334

    Article  Google Scholar 

  5. Gotaas HT, Skeie GO, Gilhus NE (2016) Myasthenia gravis and amyotrophic lateral sclerosis: a pathogenic overlap. Neuromuscul Disord 26:337–341. doi:10.1016/j.nmd.2016.03.003

    Article  PubMed  Google Scholar 

  6. Tzartos JS, Zisimopoulou P, Rentzos M et al (2014) LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 1:80–87. doi:10.1002/acn3.26

    Article  CAS  PubMed  Google Scholar 

  7. Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100. doi:10.1016/j.jaut.2013.12.011

    Article  CAS  PubMed  Google Scholar 

  8. Henkel JS, Beers DR, Wen S et al (2013) Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med 5:64–79. doi:10.1002/emmm.201201544

    Article  CAS  PubMed  Google Scholar 

  9. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. PNAS USA 104:19446–19451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhao W, Xie W, Xiao Q, Beers DR, Appel SH (2006) Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J Neurochem 99:1176–1187

    Article  CAS  PubMed  Google Scholar 

  11. Beers DR, Henkel JS, Zhao W et al (2011) Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain 134:1293–1314. doi:10.1093/brain/awr074

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The ALS Registry is supported by a Grant from the Emilia Romagna Regional Health Authority.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jessica Mandrioli.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Pasqua, S., Cavallieri, F., D’Angelo, R. et al. Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?. Neurol Sci 38, 441–444 (2017). https://doi.org/10.1007/s10072-016-2787-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2787-3

Keywords

Navigation